Historical source coverage
126 selected records with a cited source date in 2017. This archive is selective and does not imply continuous monitoring or complete historical coverage.
Literature metadata · Abaloparatide
PeptideScanner retained PubMed bibliographic metadata for PMID 27894941 at 2026-07-30T21:22:58.009Z. PubMed recorded a metadata revision date of 2017-12-23 and an Entrez history date of 2016-11-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials · Teriparatide
PeptideScanner retained ClinicalTrials.gov record NCT01705587 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-12-12, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Regulatory · Semaglutide
The official Drugs@FDA dataset lists original submission 1 for NDA 209637 with status AP dated 2017-12-05, and names semaglutide among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Clinical trials · Semaglutide
PeptideScanner retained ClinicalTrials.gov record NCT02079870 at 2026-07-30T21:22:00.245Z. Its registry update date was 2017-12-02, and PeptideScanner's reviewed identity mapping was semaglutide.
Source: ClinicalTrials.gov ↗
Regulatory · Octreotide
The Federal Register published notice 2017-25920, attributed to FDA and its parent HHS department, on 2017-12-01. Its official title is “Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.
Source: Federal Register via GovInfo ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT01588418 at 2026-07-30T21:22:00.248Z. Its registry update date was 2017-11-24, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT01762943 at 2026-07-30T21:22:00.263Z. Its registry update date was 2017-11-20, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Literature metadata · Linaclotide
PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · Linaclotide
PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · BPC-157
PubMed lists PMID 24486708 in European journal of pharmacology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-31 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · Linaclotide
PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · BPC-157
PubMed lists PMID 25912999 in Experimental eye research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-24 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · BPC-157
PubMed lists PMID 27060013 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-04-06 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · BPC-157
PubMed lists PMID 27815173 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-11-01 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata · Epitalon
PeptideScanner retained PubMed bibliographic metadata for PMID 12101568 at 2026-07-30T21:22:56.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-07-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 15381050 at 2026-07-30T21:22:56.969Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2004-09-24. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 15774286 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-03-19. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 15840402 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-04-21. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 16117343 at 2026-07-30T21:22:56.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-08-25. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 16369461 at 2026-07-30T21:22:56.972Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-12-22. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 16583442 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-04. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 16609979 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-13. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Linaclotide
PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 18594781 at 2026-07-30T21:22:56.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-07-03. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Linaclotide
PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 19465062 at 2026-07-30T21:22:56.982Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-05-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Linaclotide
PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 19903499 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-12. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 19931318 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 20190676 at 2026-07-30T21:22:57.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-03-02. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Linaclotide
PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Tesamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 25402764 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-11-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 26979527 at 2026-07-30T21:22:57.999Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2016-03-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 11742568 at 2026-07-30T21:22:56.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2001-12-18. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 11978191 at 2026-07-30T21:22:56.966Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-04-30. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · BPC-157
PeptideScanner retained PubMed bibliographic metadata for PMID 14554208 at 2026-07-30T21:22:56.968Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2003-10-14. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Tesamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 17575575 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Tesamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 18690162 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-12. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Tesamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 18724445 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-30. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Tesamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 18828236 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-10-03. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 23407924 at 2026-07-30T21:22:57.984Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-02-15. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 23884489 at 2026-07-30T21:22:57.985Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-07-26. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 25230094 at 2026-07-30T21:22:57.990Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-09-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 25470471 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-12-04. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 21073357 at 2026-07-30T21:22:57.974Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-11-16. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 21597671 at 2026-07-30T21:22:57.976Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-05-21. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata · Afamelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 23277150 at 2026-07-30T21:22:57.983Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-01-02. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT03061604 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-14, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Regulatory · Linaclotide
DailyMed lists Structured Product Labeling version 17 for the reviewed Linaclotide label family with a published date of 2017-11-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT00422058 at 2026-07-30T21:22:00.247Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT00781937 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01557166 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Tesamorelin
PeptideScanner retained ClinicalTrials.gov record NCT01263717 at 2026-07-30T21:22:00.255Z. Its registry update date was 2017-10-30, and PeptideScanner's reviewed identity mapping was tesamorelin.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT02647944 at 2026-07-30T21:22:00.265Z. Its registry update date was 2017-10-27, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Regulatory · Dulaglutide
DailyMed lists Structured Product Labeling version 25 for the reviewed Dulaglutide label family with a published date of 2017-10-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Exenatide
The official Drugs@FDA dataset lists original submission 1 for NDA 209210 with status AP dated 2017-10-20, and names exenatide synthetic among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Clinical trials · Lanreotide
PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.
Source: ClinicalTrials.gov ↗
Literature metadata · Bremelanotide
PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Regulatory · Lixisenatide
DailyMed lists Structured Product Labeling version 5 for the reviewed Lixisenatide label family with a published date of 2017-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Abaloparatide
DailyMed lists Structured Product Labeling version 2 for the reviewed Abaloparatide label family with a published date of 2017-10-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT00589472 at 2026-07-30T21:22:00.251Z. Its registry update date was 2017-10-06, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT01969149 at 2026-07-30T21:22:00.262Z. Its registry update date was 2017-10-06, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Regulatory · Semaglutide
The Federal Register published notice 2017-21176, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.
Source: Federal Register via GovInfo ↗
Regulatory · Glucagon + 2 more
The Federal Register published notice 2017-21202, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide and Teriparatide.
Source: Federal Register via GovInfo ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT00456885 at 2026-07-30T21:23:14.762Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Regulatory · Lixisenatide
DailyMed lists Structured Product Labeling version 4 for the reviewed Lixisenatide label family with a published date of 2017-09-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Dulaglutide
DailyMed lists Structured Product Labeling version 23 for the reviewed Dulaglutide label family with a published date of 2017-09-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT02321878 at 2026-07-30T21:23:14.758Z. Its registry update date was 2017-09-01, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Glucagon
PeptideScanner retained ClinicalTrials.gov record NCT02516150 at 2026-07-30T21:23:14.758Z. Its registry update date was 2017-08-31, and PeptideScanner's reviewed identity mapping was glucagon.
Source: ClinicalTrials.gov ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Regulatory · Dulaglutide
DailyMed lists Structured Product Labeling version 22 for the reviewed Dulaglutide label family with a published date of 2017-08-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Teriparatide
PeptideScanner retained ClinicalTrials.gov record NCT01153425 at 2026-07-30T21:23:14.757Z. Its registry update date was 2017-08-04, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT00978393 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-07-27, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Regulatory · Linaclotide
DailyMed lists Structured Product Labeling version 16 for the reviewed Linaclotide label family with a published date of 2017-07-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT00600886 at 2026-07-30T21:23:14.761Z. Its registry update date was 2017-07-02, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Regulatory · Dulaglutide
DailyMed lists Structured Product Labeling version 21 for the reviewed Dulaglutide label family with a published date of 2017-06-28. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Linaclotide
DailyMed lists Structured Product Labeling version 15 for the reviewed Linaclotide label family with a published date of 2017-06-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Leuprolide + 1 more
The Federal Register published notice 2017-12908, attributed to FDA and its parent HHS department, on 2017-06-21. Its official title is “Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.
Source: Federal Register via GovInfo ↗
Clinical trials · Linaclotide
PeptideScanner retained ClinicalTrials.gov record NCT02291679 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-06-15, and PeptideScanner's reviewed identity mapping was linaclotide.
Source: ClinicalTrials.gov ↗
Regulatory · Linaclotide
DailyMed lists Structured Product Labeling version 14 for the reviewed Linaclotide label family with a published date of 2017-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT00225420 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-06-01, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Literature metadata · Abaloparatide
PeptideScanner retained PubMed bibliographic metadata for PMID 28160873 at 2026-07-30T21:25:18.679Z. PubMed recorded a metadata revision date of 2017-05-31 and an Entrez history date of 2017-02-06. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01562678 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-05-31, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Literature metadata · Ipamorelin
PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT02107391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-24, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Regulatory · Liraglutide
The Federal Register published notice 2017-10326, attributed to FDA and its parent HHS department, on 2017-05-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.
Source: Federal Register via GovInfo ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Clinical trials · Teriparatide
PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Regulatory · Abaloparatide
DailyMed lists Structured Product Labeling version 1 for the reviewed Abaloparatide label family with a published date of 2017-05-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01739049 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-05-04, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Regulatory · Abaloparatide
The official Drugs@FDA dataset lists original submission 1 for NDA 208743 with status AP dated 2017-04-28, and names abaloparatide among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Literature metadata · Ziconotide
PubMed lists PMID 16845440 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2006-06 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Clinical trials · Ipamorelin
PeptideScanner retained ClinicalTrials.gov record NCT00672074 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was ipamorelin.
Source: ClinicalTrials.gov ↗
Clinical trials · Ipamorelin
PeptideScanner retained ClinicalTrials.gov record NCT01280344 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was ipamorelin.
Source: ClinicalTrials.gov ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT00182754 at 2026-07-30T21:24:24.234Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT00650546 at 2026-07-30T21:24:24.230Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Teriparatide
PeptideScanner retained ClinicalTrials.gov record NCT01400516 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Leuprolide
PeptideScanner retained ClinicalTrials.gov record NCT00380406 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-05, and PeptideScanner's reviewed identity mapping was leuprolide.
Source: ClinicalTrials.gov ↗
Clinical trials · Semaglutide
PeptideScanner retained ClinicalTrials.gov record NCT02022254 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-04-04, and PeptideScanner's reviewed identity mapping was semaglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT00332969 at 2026-07-30T21:25:36.783Z. Its registry update date was 2017-03-31, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Literature metadata · Dulaglutide
PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT00318461 at 2026-07-30T21:25:37.025Z. Its registry update date was 2017-03-07, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT01484873 at 2026-07-30T21:25:36.820Z. Its registry update date was 2017-03-03, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT00855439 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-03-01, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT03068065 at 2026-07-30T21:25:36.832Z. Its registry update date was 2017-03-01, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01518101 at 2026-07-30T21:25:36.782Z. Its registry update date was 2017-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT00171886 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-02-24, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01128894 at 2026-07-30T21:25:36.852Z. Its registry update date was 2017-02-23, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Exenatide
PeptideScanner retained ClinicalTrials.gov record NCT02325960 at 2026-07-30T21:25:37.027Z. Its registry update date was 2017-02-23, and PeptideScanner's reviewed identity mapping was exenatide.
Source: ClinicalTrials.gov ↗
Literature metadata · Ziconotide
PubMed lists PMID 28195861 in A & A case reports as Case Reports, Journal Article, with publication-date metadata of 2017-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Regulatory · Linaclotide
DailyMed lists Structured Product Labeling version 13 for the reviewed Linaclotide label family with a published date of 2017-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory · Dulaglutide
DailyMed lists Structured Product Labeling version 19 for the reviewed Dulaglutide label family with a published date of 2017-02-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT00873223 at 2026-07-30T21:25:36.788Z. Its registry update date was 2017-01-26, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01515592 at 2026-07-30T21:25:36.784Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01516255 at 2026-07-30T21:25:36.817Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01518166 at 2026-07-30T21:25:36.824Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01620476 at 2026-07-30T21:25:37.025Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01507272 at 2026-07-30T21:25:36.818Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01507337 at 2026-07-30T21:25:36.779Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01508806 at 2026-07-30T21:25:36.763Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Liraglutide
PeptideScanner retained ClinicalTrials.gov record NCT01620463 at 2026-07-30T21:25:36.783Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.
Source: ClinicalTrials.gov ↗
Regulatory · Plecanatide
The official Drugs@FDA dataset lists original submission 1 for NDA 208745 with status AP dated 2017-01-19, and names plecanatide among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Clinical trials · Octreotide
PeptideScanner retained ClinicalTrials.gov record NCT00223691 at 2026-07-30T21:25:36.812Z. Its registry update date was 2017-01-18, and PeptideScanner's reviewed identity mapping was octreotide.
Source: ClinicalTrials.gov ↗